🧐 this receipt from CVS, where the insurance is billed $363, and the customer pays $64.45/90 tabs of Atorvastatin. Here, that would be about $1.49 + a fair $5 member fee.
For the doubters: a stock bottle that cost us just $11.88/1000ct. We can buy 5,425 tablets for $64.45!!
.@Forbes released its 2023 philanthropy scorecard and once again, @johnarnold and @LauraArnoldFdn earned the highest score — a rare 5 — for their charitable giving. Only 11 people from the #Forbes400 have given away more than 20% of their wealth: https://t.co/WCmz0z98CZ
@nbcwashington Rock Creek Park is a jewel of immeasurable value in the heart of the city. If it did not exist, we would gladly pay tens or hundreds of millions of dollars to have a place for walkers, runners and cyclists to enjoy nature free of cars.
$43,000,000 was spent in three years with very little research or anything else to show for it. 130 students could have had a totally free BU education (plus room/board) for four years instead . Or 10 faculty chairs could have been endowed in perpetuity. What a waste of money.
"Civica Rx significantly increased supply security and lowered the cost in aggregate...these medications are critical to patient care & have been prone to shortages." - Carter Dredge, @SSMHealth@nejmcatalyst@CivicaRx https://t.co/CPShtY3DyZ
Big PBMs say “Drugmakers alone have the power to set prices.”
Then how is that the same PBM set five different prices for the same drug, at the same pharmacy, on the same day, where the delta between the bookends had an over 10x difference?
Our latest: https://t.co/mKiwV7UmYb
Do Plan Sponsors Understand How Their PBMs Make Money?
My $0.02 on how #PBMs' profit model has evolved—and why a plan sponsor can feel satisfied with PBM transparency while remaining unaware of how its PBM actually earns money.
@psgconsults
https://t.co/4Ln83JU9cK
Do Plan Sponsors Understand How Their PBMs Make Money?
My $0.02 on how #PBMs' profit model has evolved—and why a plan sponsor can feel satisfied with PBM transparency while remaining unaware of how its PBM actually earns money.
@psgconsults
https://t.co/4Ln83JU9cK
“Across a selection of these so-called specialty generic drugs, Cigna and CVS’s prices were at least 24 times higher on average than roughly what the medicines’ manufacturers charge, the @WSJ found.” - @joewalkerWSJ
https://t.co/0eo2F4Gxyt
"Civica is the only pharma created specifically to address drug shortages. The drugs we deliver are not chosen for return-on-investment. They are chosen by hospitals because they are in shortage or at risk of shortage." @coukell, @CivicaRx at U.S. Subcommittee on Health hearing
ICYMI - @mganio_ASHP @coukell@CivicaRx@ASHPOfficial provided great recs on fixing the drug shortages problem during todays hearing https://t.co/nVyA3hczwv
"Generic drugs should be cheap, but insurers are charging thousands of dollars for them" (NB - in place of "insurer" read "PBM," though sometimes they are one and the same.) https://t.co/rZECOnQXTs
Five years in less than 10 minutes. We invite you to watch and learn more about the power of partnership and collaboration. @CivicaRx https://t.co/fUkxk3Yc1s
Ukraine came to the aid of the United States after we were attacked on 9/11 and deployed troops to support the ISAF mission in Afghanistan for almost 14 years